HIF1A and glioblastoma: The median survival times (MST) of GBM patients with high HIF1A expression was 12.7 months, while that of patients with low HIF1A expression was 15.6 months, showing that GBM patients with high HIF1A expression had a poor prognosis, p = 0.001 (Figure 2I).